Plenary Session - inactive due to federal service
Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 7, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 21, 2026
Latest episodes
5.05 Measles in PA, Nature's editorial, and more (opens the original)
Read excerpt
5.05 Measles in PA, Nature's editorial, and more by Plenary Session
5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards (opens the original)
Read excerpt
5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards by Plenary Session
5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin (opens the original)
Read excerpt
5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin by Plenary Session
Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony (opens the original)
Read excerpt
Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony by Plenary Session
Reboot - I am back with Audio podcasts (opens the original)
Read excerpt
Reboot - I am back with Audio podcasts by Plenary Session
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about Plenary Session - inactive due to federal service